Dablo, Xynah Jane .
HRN: 28-42-39 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/12/2026
CEFUROXIME 500MG (TAB)
03/12/2026
03/19/2026
PO
1 Tab
BID
Thickly MSAF
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: